Literature DB >> 25520859

Ligand-activated PPARδ modulates the migration and invasion of melanoma cells by regulating Snail expression.

Sun Ah Ham1, Taesik Yoo1, Jung Seok Hwang1, Eun Sil Kang1, Won Jin Lee1, Kyung Shin Paek2, Chankyu Park1, Jin-Hoi Kim1, Jeong Tae Do1, Dae-Seog Lim3, Han Geuk Seo1.   

Abstract

Peroxisome proliferator-activated receptor (PPAR) δ is implicated in the carcinogenesis of several types of cancer. However, the therapeutic efficacy of PPARδ ligands against cancer progression is unclear. Here, we showed that PPARδ modulates the migration and invasion of melanoma cells by up-regulating Snail expression. Activation of PPARδ by GW501516, a specific ligand for PPARδ, significantly increased the migration and invasion of highly metastatic A375SM cells, but not that of low metastatic A375P cells. The migration- and invasion-promoting effects of PPARδ on A375SM cells was associated with increased Snail expression, which was accompanied by a decrease in E-cadherin expression. Furthermore, a significant concentration- and time-dependent increase in the levels of Snail mRNA and protein was observed in A375SM cells (but not A375P cells) treated with GW501516. The effects of GW501516 were almost completely abrogated by a small interfering RNA against PPARδ, suggesting that PPARδ mediates the effects of GW501516. Activation of PPARδ in SK-MEL-2 and SK-MEL-5 (but not SK-MEL-3) melanoma cell lines also led to significant increases in the expression of Snail mRNA and protein, which mirrored the invasive and migratory potential of these cell lines. These results suggest that PPARδ promotes the aggressive phenotype observed in highly metastatic melanoma cells by up-regulating Snail.

Entities:  

Keywords:  PPARδ; Snail; invasion; melanoma; migration

Year:  2014        PMID: 25520859      PMCID: PMC4266703     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.

Authors:  H-F Yuen; C-W Chua; Y-P Chan; Y-C Wong; X Wang; K-W Chan
Journal:  Histopathology       Date:  2007-04       Impact factor: 5.087

3.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

Review 4.  Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.

Authors:  Liliane Michalik; Walter Wahli
Journal:  Biochim Biophys Acta       Date:  2007-02-24

5.  Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.

Authors:  Lie Yang; Hong Zhang; Zong-Guang Zhou; Hui Yan; G Adell; Xiao-Feng Sun
Journal:  Clin Cancer Res       Date:  2011-04-29       Impact factor: 12.531

6.  Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.

Authors:  Tsutomu Imai; Akiko Horiuchi; Cuiju Wang; Kenji Oka; Satoshi Ohira; Toshio Nikaido; Ikuo Konishi
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion.

Authors:  Cecilia Sahlgren; Maria V Gustafsson; Shaobo Jin; Lorenz Poellinger; Urban Lendahl
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

8.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

9.  Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation.

Authors:  Claire B Pollock; Olga Rodriguez; Philip L Martin; Chris Albanese; Xin Li; Levy Kopelovich; Robert I Glazer
Journal:  PPAR Res       Date:  2010-12-27       Impact factor: 4.964

10.  Role of Peroxisome Proliferator-Activated Receptor β/δ and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells.

Authors:  Jeffrey D Coleman; Jerry T Thompson; Russell W Smith; Bogdan Prokopczyk; John P Vanden Heuvel
Journal:  PPAR Res       Date:  2013-05-02       Impact factor: 4.964

View more
  15 in total

1.  Metastasis regulation by PPARD expression in cancer cells.

Authors:  Xiangsheng Zuo; Weiguo Xu; Min Xu; Rui Tian; Micheline J Moussalli; Fei Mao; Xiaofeng Zheng; Jing Wang; Jeffrey S Morris; Mihai Gagea; Cathy Eng; Scott Kopetz; Dipen M Maru; Asif Rashid; Russell Broaddus; Daoyan Wei; Mien-Chie Hung; Anil K Sood; Imad Shureiqi
Journal:  JCI Insight       Date:  2017-01-12

Review 2.  Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.

Authors:  Jeffrey M Peters; Dae J Kim; Moses T Bility; Michael G Borland; Bokai Zhu; Frank J Gonzalez
Journal:  Mol Carcinog       Date:  2019-05-06       Impact factor: 4.784

3.  Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.

Authors:  Michael G Borland; Pei-Li Yao; Ellen M Kehres; Christina Lee; Amanda M Pritzlaff; Elizabeth Ola; Ashley L Wagner; Brooke E Shannon; Prajakta P Albrecht; Bokai Zhu; Boo-Hyon Kang; Gavin P Robertson; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2017-10-01       Impact factor: 4.849

Review 4.  Establishing the Role of PPARβ/δ in Carcinogenesis.

Authors:  Jeffrey M Peters; Frank J Gonzalez; Rolf Müller
Journal:  Trends Endocrinol Metab       Date:  2015-10-18       Impact factor: 12.015

5.  Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms.

Authors:  Pei-Li Yao; Li Ping Chen; Tomasz P Dobrzański; Dylan A Phillips; Bokai Zhu; Boo-Hyon Kang; Frank J Gonzalez; Jeffrey M Peters
Journal:  Oncotarget       Date:  2015-11-03

Review 6.  Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Angela Nigro; Valentina Lucia La Rosa; Paola Rossetti; Agnese Maria Chiara Rapisarda; Sandro La Vignera; Rosita Angela Condorelli; Francesco Corrado; Massimo Buscema; Rosario D'Anna
Journal:  PPAR Res       Date:  2016-12-28       Impact factor: 4.964

7.  ADAMTS1-mediated targeting of TSP-1 by PPARδ suppresses migration and invasion of breast cancer cells.

Authors:  Sun Ah Ham; Taesik Yoo; Won Jin Lee; Jung Seok Hwang; Jinwoo Hur; Kyung Shin Paek; Dae-Seog Lim; Sung Gu Han; Chi-Ho Lee; Han Geuk Seo
Journal:  Oncotarget       Date:  2017-10-06

8.  Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.

Authors:  Céline Elie-Caille; Isabelle Lascombe; Adeline Péchery; Hugues Bittard; Sylvie Fauconnet
Journal:  Mol Cell Biochem       Date:  2020-06-09       Impact factor: 3.396

Review 9.  The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor.

Authors:  Yi Liu; Jennifer K Colby; Xiangsheng Zuo; Jonathan Jaoude; Daoyan Wei; Imad Shureiqi
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

10.  The Role of PPARβ/δ in Melanoma Metastasis.

Authors:  Jonathan Chee Woei Lim; Yuet Ping Kwan; Michelle Siying Tan; Melissa Hui Yen Teo; Shunsuke Chiba; Walter Wahli; Xiaomeng Wang
Journal:  Int J Mol Sci       Date:  2018-09-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.